99 related articles for article (PubMed ID: 1493442)
21. Evidence of bone resorption-stimulating factor in adult T-cell leukemia.
Fujihira T; Eto S; Sato K; Zeki K; Oda S; Chiba S; Suzuki H
Jpn J Clin Oncol; 1985 Jun; 15(2):385-91. PubMed ID: 3874974
[TBL] [Abstract][Full Text] [Related]
22. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption.
Stashenko P; Dewhirst FE; Peros WJ; Kent RL; Ago JM
J Immunol; 1987 Mar; 138(5):1464-8. PubMed ID: 3492553
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-2 increases production and secretion of parathyroid hormone-related peptide by human T cell leukemia virus type I-infected T cells: possible role in hypercalcemia associated with adult T cell leukemia.
Ikeda K; Okazaki R; Inoue D; Ohno H; Ogata E; Matsumoto T
Endocrinology; 1993 Jun; 132(6):2551-6. PubMed ID: 8099324
[TBL] [Abstract][Full Text] [Related]
24. Multiple myeloma/hypercalcemia.
Oyajobi BO
Arthritis Res Ther; 2007; 9 Suppl 1(Suppl 1):S4. PubMed ID: 17634143
[TBL] [Abstract][Full Text] [Related]
25. Hypercalcemia, parathyroid hormone-related protein expression and human T-cell leukemia virus infection.
Prager D; Rosenblatt JD; Ejima E
Leuk Lymphoma; 1994 Aug; 14(5-6):395-400. PubMed ID: 7812198
[TBL] [Abstract][Full Text] [Related]
26. Raised plasma concentrations of parathyroid hormone related peptide in hypercalcemic multiple myeloma.
Horiuchi T; Miyachi T; Arai T; Nakamura T; Mori M; Ito H
Horm Metab Res; 1997 Sep; 29(9):469-71. PubMed ID: 9370119
[TBL] [Abstract][Full Text] [Related]
27. [Hypercalcemia in myeloma].
Abe M
Nihon Rinsho; 2007 Dec; 65(12):2245-9. PubMed ID: 18069268
[TBL] [Abstract][Full Text] [Related]
28. [Clinical classification of adult T-cell leukemia and its complications].
Tamura K
Rinsho Byori; 1996 Jan; 44(1):19-23. PubMed ID: 8691635
[TBL] [Abstract][Full Text] [Related]
29. Hypercalcemia associated with hematologic malignancies.
Grauer A
Recent Results Cancer Res; 1994; 137():114-21. PubMed ID: 7878291
[No Abstract] [Full Text] [Related]
30. Interleukin 1 gene expression in adult T cell leukemia.
Wano Y; Hattori T; Matsuoka M; Takatsuki K; Chua AO; Gubler U; Greene WC
J Clin Invest; 1987 Sep; 80(3):911-6. PubMed ID: 2887587
[TBL] [Abstract][Full Text] [Related]
31. Hypercalcemia and osteoclast proliferation in adult T-cell leukemia.
Kiyokawa T; Yamaguchi K; Takeya M; Takahashi K; Watanabe T; Matsumoto T; Lee SY; Takatsuki K
Cancer; 1987 Mar; 59(6):1187-91. PubMed ID: 2880656
[TBL] [Abstract][Full Text] [Related]
32. [Hypercalcemia of T-cell leukemia in adults].
Jean-Baptiste G; Arfi S; Plumelle Y; Panelatti G; Mangin JL; Pascaline N
Rev Rhum Ed Fr; 1993 Apr; 60(4):292-8. PubMed ID: 8167627
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers.
Tsukasaki K; Miller CW; Kubota T; Takeuchi S; Fujimoto T; Ikeda S; Tomonaga M; Koeffler HP
Cancer Res; 2001 May; 61(9):3770-4. PubMed ID: 11325850
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
35. Production of interleukin 1 beta, a potent bone resorbing cytokine, by cultured human myeloma cells.
Yamamoto I; Kawano M; Sone T; Iwato K; Tanaka H; Ishikawa H; Kitamura N; Lee K; Shigeno C; Konishi J
Cancer Res; 1989 Aug; 49(15):4242-6. PubMed ID: 2787204
[TBL] [Abstract][Full Text] [Related]
36. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
[TBL] [Abstract][Full Text] [Related]
38. [Studies on association between the ATL and the development of multiple malignant neoplasms--analysis of 1171 cases of hematological malignancies during the past 24 years].
Imamura N; Inada T; Kuramoto A
Rinsho Ketsueki; 1989 Oct; 30(10):1744-50. PubMed ID: 2687507
[TBL] [Abstract][Full Text] [Related]
39. Evidence for the secretion of an osteoclast stimulating factor in myeloma.
Mundy GR; Raisz LG; Cooper RA; Schechter GP; Salmon SE
N Engl J Med; 1974 Nov; 291(20):1041-6. PubMed ID: 4413338
[No Abstract] [Full Text] [Related]
40. Two squamous cell carcinomas not associated with humoral hypercalcemia produce a potent bone resorption-stimulating factor which is interleukin-1 alpha.
Fried RM; Voelkel EF; Rice RH; Levine L; Gaffney EV; Tashjian AH
Endocrinology; 1989 Aug; 125(2):742-51. PubMed ID: 2546747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
